Main Session
Sep 30
PQA 08 - Gastrointestinal Cancer, Nonmalignant Disease, Palliative Care

3558 - Cardiomyocytes Upregulated the PD-L1 Expression to Alleviate Cardiac Injury Induced by Irradiation Combined with Anti-PD-1 Antibody: An In Vitro and In Vivo Study

02:30pm - 03:45pm PT
Hall F
Screen: 22
POSTER

Presenter(s)

Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei

Y. Zhou1, Y. Wu2, J. Wang2, N. Zhang3, S. Wang4, X. S. Ye5, and Q. Li6; 1Hebei General Hospital, Shijiazhuang, China, 2Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China, 3Shijiazhuang People’s Hospital, Shijiazhuang, China, 4The Fourth Hospital of Hebei Medical University, Shijiazhuang, China, 5Clinical Medical College of Hebei University of Engineering, Handan, China, 6General Hospital of Hebei, Shijiazhuang, Hebei, China

Purpose/Objective(s):

Preclinical studies suggest that irradiation combined with anti-PD-1 antibody (iRT) exacerbates cardiac injury in mice, which is mediated by CD8-positive cell. We delivered with different irradiation doses and in combination with anti-PD-1 antibody to cardiomyocytes, both in vivo and in vitro, to investigated the PD-L1 expression in cardiomyocytes, and analyzed the underlying mechanisms.

Materials/Methods:

AC16 human cardiomyocytes (AC16 cells) were exposed to 0, 6Gy, or 10Gy irradiation. PD-L1 expression was assessed at 24h, 48h, and 72h by flow cytometry, qPCR, western blot, and immunofluorescence. Cell viability, apoptosis, and cytokine levels (IL-6, IL-10, MCP-1, CCL5, CXCL10) were detected. We knockdowned PD-L1 via siRNA (siPD-L1) to evaluate its function in AC16 cells. PBMCs or CD8+ T cells were co-cultured with siNC and siPD-L1 AC16 cells following irradiation at E:T 0:1, 5:1 and 10:1, and they were administrated with PD-1 inhibitors at different concentration. In vivo, C57BL/6J mice model of iRT-induced myocardial injury was established, and the heart tissue was analyzed for PD-L1 expression and CD8+T cells infiltration.

Results:

Irradiation with 10Gy upregulated PD-L1 expression on membrane, both in cytoplasm at 48h, and accumulation in the nucleus at 72h. After irradiation, the levels of IL-6, MCP-1, CCL5, and CXCL10 increased and IL-10 decreased in supernatant. Cardiomyocyte viability was inhibited, and apoptosis of cell increased. When PD-L1 was knockdowned in AC16 cells, we found cytokine release was exacerbated. Co-culture with activated CD8+ T cells inhibited cardiomyocyte viability, and this effect was dependent on CD8+T-cell density and co-culture time. In vivo, upregulation of PD-L1 in myocardial cells alleviate cardiac injury when combined irradiation with anti-PD-1 antibody, and survival were observed in mice without significant myocardial necrosis.

Conclusion:

PD-L1 Upregulation in cardiomyocytes might protect iRT-induced cardiac injury, which probably modulate inflammatory cytokines and CD8+ T-cell infiltration. CD8+ T-cell density and activation are the key issues in cardiomyocyte injury during iRT.